Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective EP4 receptor antagonistic substance for treatment of cancer

Selective EP4 receptor antagonistic substance for treatment of cancer

US Patent 9688674 · Granted Jun 27, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective EP4 receptor antagonistic substance for treatment of cancer2023
Selective EP4 receptor antagonistic substance for treatment of cancer2023
Selective EP4 receptor antagonistic substance for treatment of cancer2023
Selective EP4 receptor antagonistic substance for treatment of cancer2023
Uses of benzimidazole derivative for nocturnal acid breakthrough2021
EP4 inhibitors and use thereof2021
EP4 inhibitors and use thereof2021
Ghrelin receptor agonist for treatment of cachexia2021
Selective EP4 receptor antagonistic substance for treatment of cancer2021
Selective EP4 receptor antagonistic substance for treatment of cancer2021
Selective EP4 receptor antagonistic substance for treatment of cancer2021
Selective EP4 receptor antagonistic substance for treatment of cancer2021